NLRP3
NACHT, LRR and PYD domains-containing protein 3
Also known as: NLRP3_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q96P20
- Gene
- NLRP3
- Canonical length
- 1036 aa
- Protein class
- Cancer-related genes, Human disease related genes, Predicted intracellular proteins
- Quaternary structure
- Homodecamer
OverviewNCBI Gene
No narrative summary is available for NLRP3 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
1036 residues, UniProt reviewed canonical sequence.
>Q96P20|NLRP3
1 MKMASTRCKL ARYLEDLEDV DLKKFKMHLE DYPPQKGCIP LPRGQTEKAD HVDLATLMID
61 FNGEEKAWAM AVWIFAAINR RDLYEKAKRD EPKWGSDNAR VSNPTVICQE DSIEEEWMGL
121 LEYLSRISIC KMKKDYRKKY RKYVRSRFQC IEDRNARLGE SVSLNKRYTR LRLIKEHRSQ
181 QEREQELLAI GKTKTCESPV SPIKMELLFD PDDEHSEPVH TVVFQGAAGI GKTILARKMM
241 LDWASGTLYQ DRFDYLFYIH CREVSLVTQR SLGDLIMSCC PDPNPPIHKI VRKPSRILFL
301 MDGFDELQGA FDEHIGPLCT DWQKAERGDI LLSSLIRKKL LPEASLLITT RPVALEKLQH
361 LLDHPRHVEI LGFSEAKRKE YFFKYFSDEA QARAAFSLIQ ENEVLFTMCF IPLVCWIVCT
421 GLKQQMESGK SLAQTSKTTT AVYVFFLSSL LQPRGGSQEH GLCAHLWGLC SLAADGIWNQ
481 KILFEESDLR NHGLQKADVS AFLRMNLFQK EVDCEKFYSF IHMTFQEFFA AMYYLLEEEK
541 EGRTNVPGSR LKLPSRDVTV LLENYGKFEK GYLIFVVRFL FGLVNQERTS YLEKKLSCKI
601 SQQIRLELLK WIEVKAKAKK LQIQPSQLEL FYCLYEMQEE DFVQRAMDYF PKIEINLSTR
661 MDHMVSSFCI ENCHRVESLS LGFLHNMPKE EEEEEKEGRH LDMVQCVLPS SSHAACSHGL
721 VNSHLTSSFC RGLFSVLSTS QSLTELDLSD NSLGDPGMRV LCETLQHPGC NIRRLWLGRC
781 GLSHECCFDI SLVLSSNQKL VELDLSDNAL GDFGIRLLCV GLKHLLCNLK KLWLVSCCLT
841 SACCQDLASV LSTSHSLTRL YVGENALGDS GVAILCEKAK NPQCNLQKLG LVNSGLTSVC
901 CSALSSVLST NQNLTHLYLR GNTLGDKGIK LLCEGLLHPD CKLQVLELDN CNLTSHCCWD
961 LSTLLTSSQS LRKLSLGNND LGDLGVMMFC EVLKQQSCLL QNLGLSEMYF NYETKSALET
1021 LQEEKPELTV VFEPSWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NLRP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 52 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 52 nTPM
- appendix: 9.4 nTPM
- adipose tissue: 7.9 nTPM
- gallbladder: 6.1 nTPM
- urinary bladder: 5.9 nTPM
- smooth muscle: 4.5 nTPM
Single-cell type
- monocytes: 260 nCPM
- neutrophils: 173 nCPM
- microglia: 67 nCPM
- macrophages: 48 nCPM
- cdc: 29 nCPM
- monocyte progenitors: 24 nCPM
Immune cell
- basophil: 130 nTPM
- myeloid DC: 37 nTPM
- classical monocyte: 36 nTPM
- intermediate monocyte: 22 nTPM
- total PBMC: 12 nTPM
- non-classical monocyte: 12 nTPM
Brain region
- white matter: 9.3 nTPM
- medulla oblongata: 6.4 nTPM
- spinal cord: 5.9 nTPM
- pons: 5.8 nTPM
- hypothalamus: 5.3 nTPM
- thalamus: 5.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NLRP3.
Disease | AllUniProt
Conditions NLRP3 is implicated in, by any mechanism.
- Familial cold autoinflammatory syndrome 1 (FCAS1) MIM:120100
- Muckle-Wells syndrome (MWS) MIM:191900
- Chronic infantile neurologic cutaneous and articular syndrome (CINCA) MIM:607115
- Keratoendothelitis fugax hereditaria (KEFH) MIM:148200
- Deafness, autosomal dominant, 34, with or without inflammation (DFNA34) MIM:617772
Disease | GeneticClinVar
65 pathogenic / likely-pathogenic of 1,248 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Familial cold autoinflammatory syndrome 1
- Cryopyrin associated periodic syndrome
- Familial amyloid nephropathy with urticaria AND deafness
- Chronic infantile neurological, cutaneous and articular syndrome
- Autoinflammatory syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.14
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cellular response to lipopolysaccharide
- cellular response to virus
- defense response
- detection of biotic stimulus
- inflammatory response
- innate immune response
- negative regulation of acute inflammatory response
- negative regulation of inflammatory response
- negative regulation of interleukin-1 beta production
- negative regulation of non-canonical NF-kappaB signal transduction
- NLRP3 inflammasome complex assembly
- osmosensory signaling pathway
- pattern recognition receptor signaling pathway
- positive regulation of inflammatory response
- positive regulation of interleukin-1 beta production
- positive regulation of interleukin-4 production
- positive regulation of NF-kappaB transcription factor activity
- positive regulation of non-canonical NF-kappaB signal transduction
- positive regulation of T-helper 2 cell cytokine production
- positive regulation of T-helper 2 cell differentiation
- positive regulation of transcription by RNA polymerase II
- positive regulation of type 2 immune response
- protein homooligomerization
- protein maturation
- pyroptotic inflammatory response
- regulation of inflammatory response
- signal transduction
Molecular functions
- ADP binding
- ATP binding
- ATP hydrolysis activity
- cysteine-type endopeptidase activator activity
- DNA-binding transcription factor binding
- identical protein binding
- molecular adaptor activity
- molecular condensate scaffold activity
- molecular sensor activity
- peptidoglycan binding
- phosphatidylinositol phosphate binding
- phosphatidylinositol-4-phosphate binding
- protein-macromolecule adaptor activity
- sequence-specific DNA binding
- signaling adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Leucine-rich repeat
- DAPIN domain
- NACHT nucleoside triphosphatase
- Death-like domain superfamily
- P-loop containing nucleoside triphosphate hydrolase
- NACHT-associated domain
- Leucine-rich repeat domain superfamily
- NOD1/2, winged helix domain
- NACHT, LRR and PYD domains-containing protein, helical domain HD2
- NLRP family, innate immunity and inflammation regulators
- PAAD/DAPIN/Pyrin domain
- NACHT domain
- Leucine Rich repeat
- Fish-specific NACHT associated domain
- NLRC4 helical domain HD2
- NOD2 winged helix domain
KeywordsUniProt
- Activator
- ADP-ribosylation
- Amyloidosis
- ATP-binding
- Cytoplasm
- Cytoskeleton
- Deafness
- Disulfide bond
- Endoplasmic reticulum
- Golgi apparatus
- Hydrolase
- Immunity
- Inflammasome
- Inflammatory response
- Innate immunity
- Isopeptide bond
- Leucine-rich repeat
- Lipoprotein
- Membrane
- Mitochondrion
- Non-syndromic deafness
- Nucleotide-binding
- Nucleus
- Palmitate
- Phosphoprotein
- Repeat
- Secreted
- Transcription
- Transcription regulation
- Ubl conjugation
InteractionsUniProt · HPA
Protein binding partners of NLRP3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NLRP3 as an antibody target. Whether an autoantibody or antibody against NLRP3 could matter depends on whether native NLRP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NLRP3 is annotated as secreted, so native NLRP3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label NLRP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...